Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Urso

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Biomolecules|January 25, 2025
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate AdenocarcinomaIlham Badrane, Angelo Castello, Matteo Brunelli, et al.
Endocrine|August 26, 2022
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature reviewLuca Urso, Alberto Nieri, Ilaria Rambaldi, et al.
Cancers|May 14, 2025
<sup>68</sup>Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and PerspectivesLuca Urso, Rebecca Napolitano, Giorgia Speltri, et al.
Journal of Cancer Research and Clinical Oncology|February 26, 2022
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectivesLuca Urso, Angelo Castello, Giovanni Christian Rocca, et al.
Cancers|January 21, 2023
Rectal Sparing Approaches after Neoadjuvant Treatment for Rectal Cancer: A Systematic Review and Meta-Analysis Comparing Local Excision and Watch and WaitQuoc Riccardo Bao, Stefania Ferrari, Giulia Capelli, et al.
Biomedicines|October 27, 2022
The Role of [<sup>18</sup>F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary ApproachLuca Urso, Giovanni Christian Rocca, Francesca Borgia, et al.
Cancers|July 29, 2025
Quality of Life in Rectal Cancer Treatments: An Updated Systematic Review of Randomized Controlled Trials (2013-2023)Silvia Negro, Francesca Bergamo, Lorenzo Dell'Atti, et al.
Pharmaceutics|September 28, 2021
<sup>90</sup>Y/<sup>177</sup>Lu-DOTATOC: From Preclinical Studies to Application in HumansLicia Uccelli, Alessandra Boschi, Corrado Cittanti, et al.
Pharmaceutics|October 27, 2022
Glucose Metabolism Modification Induced by Radioligand Therapy with [<sup>177</sup>Lu]Lu/[<sup>90</sup>Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 TrialLuca Urso, Stefano Panareo, Angelo Castello, et al.
Frontiers in Oncology|October 17, 2022
Obesity may not be related to pathologic response in locally advanced rectal cancer following neoadjuvant chemoradiotherapyQuoc Riccardo Bao, Filippo Crimì, Giovanni Valotto, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Biomolecules|January 25, 2025
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate AdenocarcinomaIlham Badrane, Angelo Castello, Matteo Brunelli, et al.
Endocrine|August 26, 2022
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature reviewLuca Urso, Alberto Nieri, Ilaria Rambaldi, et al.
Cancers|May 14, 2025
<sup>68</sup>Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and PerspectivesLuca Urso, Rebecca Napolitano, Giorgia Speltri, et al.
Journal of Cancer Research and Clinical Oncology|February 26, 2022
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectivesLuca Urso, Angelo Castello, Giovanni Christian Rocca, et al.
Cancers|January 21, 2023
Rectal Sparing Approaches after Neoadjuvant Treatment for Rectal Cancer: A Systematic Review and Meta-Analysis Comparing Local Excision and Watch and WaitQuoc Riccardo Bao, Stefania Ferrari, Giulia Capelli, et al.
Biomedicines|October 27, 2022
The Role of [<sup>18</sup>F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary ApproachLuca Urso, Giovanni Christian Rocca, Francesca Borgia, et al.
Cancers|July 29, 2025
Quality of Life in Rectal Cancer Treatments: An Updated Systematic Review of Randomized Controlled Trials (2013-2023)Silvia Negro, Francesca Bergamo, Lorenzo Dell'Atti, et al.
Pharmaceutics|September 28, 2021
<sup>90</sup>Y/<sup>177</sup>Lu-DOTATOC: From Preclinical Studies to Application in HumansLicia Uccelli, Alessandra Boschi, Corrado Cittanti, et al.
Pharmaceutics|October 27, 2022
Glucose Metabolism Modification Induced by Radioligand Therapy with [<sup>177</sup>Lu]Lu/[<sup>90</sup>Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 TrialLuca Urso, Stefano Panareo, Angelo Castello, et al.
Frontiers in Oncology|October 17, 2022
Obesity may not be related to pathologic response in locally advanced rectal cancer following neoadjuvant chemoradiotherapyQuoc Riccardo Bao, Filippo Crimì, Giovanni Valotto, et al.
Pageof 10